 Layne Dylla
Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Illness | 5 | 2023 | 661 | 2.330 |
Why?
| | Stroke | 5 | 2023 | 1046 | 2.270 |
Why?
| | Hyperoxia | 4 | 2023 | 97 | 1.800 |
Why?
| | Brain Ischemia | 2 | 2023 | 309 | 1.440 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2020 | 124 | 1.330 |
Why?
| | Oxygen | 4 | 2023 | 854 | 1.030 |
Why?
| | Emergency Medical Services | 3 | 2022 | 587 | 1.010 |
Why?
| | Brain Injuries, Traumatic | 2 | 2023 | 310 | 0.820 |
Why?
| | Guideline Adherence | 2 | 2022 | 520 | 0.750 |
Why?
| | Arterial Pressure | 1 | 2020 | 99 | 0.710 |
Why?
| | Perineum | 1 | 2018 | 29 | 0.640 |
Why?
| | Mountaineering | 1 | 2017 | 47 | 0.610 |
Why?
| | Intensive Care Units | 1 | 2021 | 633 | 0.590 |
Why?
| | Hypoxia | 2 | 2021 | 957 | 0.580 |
Why?
| | Acclimatization | 1 | 2017 | 133 | 0.560 |
Why?
| | Altitude Sickness | 1 | 2017 | 163 | 0.550 |
Why?
| | Dexamethasone | 1 | 2018 | 319 | 0.540 |
Why?
| | Pneumonia | 1 | 2021 | 579 | 0.520 |
Why?
| | Wounds and Injuries | 1 | 2021 | 697 | 0.480 |
Why?
| | Altitude | 1 | 2017 | 422 | 0.460 |
Why?
| | Glucocorticoids | 1 | 2018 | 545 | 0.460 |
Why?
| | Patient Education as Topic | 1 | 2017 | 696 | 0.430 |
Why?
| | Sarcoma, Ewing | 1 | 2013 | 65 | 0.420 |
Why?
| | Oximetry | 2 | 2023 | 84 | 0.420 |
Why?
| | Pain | 1 | 2018 | 736 | 0.420 |
Why?
| | Inflammation | 1 | 2021 | 2545 | 0.360 |
Why?
| | Acetaminophen | 2 | 2023 | 244 | 0.360 |
Why?
| | Retrospective Studies | 7 | 2023 | 12929 | 0.330 |
Why?
| | Humans | 17 | 2023 | 118257 | 0.290 |
Why?
| | MicroRNAs | 1 | 2013 | 633 | 0.290 |
Why?
| | Alanine Transaminase | 2 | 2023 | 151 | 0.260 |
Why?
| | Aged, 80 and over | 3 | 2021 | 6541 | 0.250 |
Why?
| | Infarction | 1 | 2023 | 16 | 0.240 |
Why?
| | Male | 8 | 2023 | 57476 | 0.230 |
Why?
| | Middle Aged | 6 | 2021 | 27511 | 0.230 |
Why?
| | Female | 9 | 2023 | 61262 | 0.230 |
Why?
| | Imines | 1 | 2022 | 8 | 0.220 |
Why?
| | Emergency Medical Dispatch | 1 | 2022 | 7 | 0.210 |
Why?
| | Benzoquinones | 1 | 2022 | 44 | 0.210 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2023 | 136 | 0.200 |
Why?
| | Information Systems | 1 | 2022 | 66 | 0.200 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2022 | 116 | 0.190 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 252 | 0.190 |
Why?
| | Patient Outcome Assessment | 1 | 2021 | 123 | 0.190 |
Why?
| | Metabolome | 1 | 2022 | 288 | 0.170 |
Why?
| | Decision Support Systems, Clinical | 1 | 2021 | 176 | 0.170 |
Why?
| | Sex Characteristics | 1 | 2023 | 667 | 0.170 |
Why?
| | Aged | 4 | 2021 | 19594 | 0.170 |
Why?
| | Emergency Service, Hospital | 2 | 2020 | 1848 | 0.160 |
Why?
| | Brain Injuries | 1 | 2023 | 480 | 0.150 |
Why?
| | Respiration, Artificial | 1 | 2021 | 543 | 0.150 |
Why?
| | Inpatients | 1 | 2021 | 387 | 0.150 |
Why?
| | Analysis of Variance | 1 | 2020 | 1288 | 0.150 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 379 | 0.150 |
Why?
| | Adult | 6 | 2023 | 31325 | 0.140 |
Why?
| | Pilot Projects | 1 | 2021 | 1405 | 0.140 |
Why?
| | Hospital Mortality | 1 | 2021 | 811 | 0.140 |
Why?
| | Early Diagnosis | 1 | 2017 | 227 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1237 | 0.140 |
Why?
| | United States | 3 | 2022 | 12491 | 0.140 |
Why?
| | Databases, Factual | 1 | 2021 | 1196 | 0.140 |
Why?
| | Waiting Lists | 1 | 2017 | 228 | 0.130 |
Why?
| | Hemodynamics | 1 | 2020 | 1002 | 0.130 |
Why?
| | Guidelines as Topic | 1 | 2017 | 261 | 0.130 |
Why?
| | Young Adult | 3 | 2021 | 10731 | 0.130 |
Why?
| | Chronic Disease | 1 | 2021 | 1630 | 0.130 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2017 | 215 | 0.130 |
Why?
| | Acute Disease | 1 | 2017 | 933 | 0.130 |
Why?
| | Practice Guidelines as Topic | 1 | 2022 | 1433 | 0.120 |
Why?
| | Quality Improvement | 1 | 2021 | 962 | 0.120 |
Why?
| | Patient Compliance | 1 | 2017 | 532 | 0.120 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4522 | 0.110 |
Why?
| | Clone Cells | 1 | 2013 | 247 | 0.110 |
Why?
| | Case-Control Studies | 1 | 2019 | 3156 | 0.110 |
Why?
| | Risk Assessment | 1 | 2021 | 3043 | 0.100 |
Why?
| | Adolescent | 2 | 2021 | 18364 | 0.100 |
Why?
| | Mass Screening | 1 | 2017 | 1048 | 0.090 |
Why?
| | Receptors, Invertebrate Peptide | 1 | 2009 | 1 | 0.090 |
Why?
| | Compound Eye, Arthropod | 1 | 2009 | 1 | 0.090 |
Why?
| | Up-Regulation | 1 | 2013 | 862 | 0.090 |
Why?
| | Wings, Animal | 1 | 2009 | 33 | 0.090 |
Why?
| | Drosophila | 1 | 2009 | 140 | 0.080 |
Why?
| | Colorado | 1 | 2017 | 4178 | 0.080 |
Why?
| | Drosophila Proteins | 1 | 2009 | 171 | 0.080 |
Why?
| | Treatment Outcome | 1 | 2021 | 9319 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2013 | 1161 | 0.080 |
Why?
| | Risk Factors | 1 | 2021 | 8958 | 0.070 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 2837 | 0.070 |
Why?
| | ErbB Receptors | 1 | 2009 | 569 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2017 | 4684 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2013 | 2262 | 0.070 |
Why?
| | Maltose | 1 | 2023 | 6 | 0.060 |
Why?
| | Urea | 1 | 2023 | 77 | 0.060 |
Why?
| | Lactates | 1 | 2022 | 86 | 0.050 |
Why?
| | Glutathione | 1 | 2022 | 324 | 0.050 |
Why?
| | Lipids | 1 | 2022 | 591 | 0.040 |
Why?
| | Sex Factors | 1 | 2022 | 1765 | 0.040 |
Why?
| | Morbidity | 1 | 2017 | 293 | 0.040 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1318 | 0.040 |
Why?
| | Prospective Studies | 1 | 2023 | 6443 | 0.020 |
Why?
| | Photoreceptor Cells, Invertebrate | 1 | 2009 | 4 | 0.020 |
Why?
| | rap1 GTP-Binding Proteins | 1 | 2009 | 5 | 0.020 |
Why?
| | Cell Polarity | 1 | 2009 | 133 | 0.020 |
Why?
| | Epithelium | 1 | 2009 | 303 | 0.020 |
Why?
| | Cadherins | 1 | 2009 | 186 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 435 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2009 | 284 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2009 | 1746 | 0.010 |
Why?
| | Mutation | 1 | 2009 | 3435 | 0.010 |
Why?
| | Animals | 1 | 2009 | 33152 | 0.000 |
Why?
|
|
Dylla's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|